Marchex, Inc. (NASDAQ:MCHX) was up 6.1% during mid-day trading on Wednesday . The company traded as high as $3.95 and last traded at $3.82, approximately 121,447 shares were traded during mid-day trading. An increase of 47% from the average daily volume of 82,865 shares. The stock had previously closed at $3.60.

A number of analysts recently issued reports on MCHX shares. ValuEngine raised Marchex from a “sell” rating to a “hold” rating in a research report on Friday, November 8th. Zacks Investment Research cut Marchex from a “buy” rating to a “hold” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Marchex presently has a consensus rating of “Buy” and a consensus price target of $6.00.

The stock has a market capitalization of $152.98 million, a price-to-earnings ratio of -63.58 and a beta of 1.58. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.28 and a current ratio of 4.28. The business has a 50-day moving average of $3.79 and a 200-day moving average of $3.74.

Marchex (NASDAQ:MCHX) last announced its earnings results on Wednesday, November 6th. The technology company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. The firm had revenue of $24.79 million during the quarter, compared to analysts’ expectations of $24.05 million. Marchex had a negative return on equity of 0.58% and a negative net margin of 4.24%. On average, research analysts predict that Marchex, Inc. will post -0.05 earnings per share for the current fiscal year.

In related news, major shareholder Edenbrook Capital, Llc acquired 100,000 shares of the firm’s stock in a transaction on Thursday, November 7th. The stock was bought at an average cost of $3.78 per share, with a total value of $378,000.00. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have acquired a total of 278,154 shares of company stock valued at $1,074,991 over the last ninety days. 18.43% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of MCHX. Tower Research Capital LLC TRC acquired a new stake in Marchex during the 2nd quarter worth approximately $45,000. AMP Capital Investors Ltd acquired a new stake in Marchex during the 2nd quarter worth approximately $62,000. Cubist Systematic Strategies LLC acquired a new stake in Marchex during the 2nd quarter worth approximately $92,000. Rhumbline Advisers lifted its position in Marchex by 15.3% during the 3rd quarter. Rhumbline Advisers now owns 37,895 shares of the technology company’s stock worth $119,000 after acquiring an additional 5,022 shares during the period. Finally, Hancock Whitney Corp acquired a new stake in Marchex during the 3rd quarter worth approximately $133,000. 55.49% of the stock is owned by institutional investors.

Marchex Company Profile (NASDAQ:MCHX)

Marchex, Inc operates as a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. Its products include Marchex Call Analytics, an analytics platform for enterprises that depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Speech Analytics that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, which enable businesses to send and receive text/SMS messages with customers; Call Monitoring; Marchex Omnichannel Analytics Cloud products, such as Marchex Search Analytics, a product for search marketers that drive phone calls from search campaigns, as well as Marchex Display and Video Analytics, a product for marketers that buy digital display advertising; Marchex Site Analytics, a product for marketers that can drive phone calls from Websites; and Marchex Social Analytics, a product for marketers that buy social media advertising.

Recommended Story: Trade War

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.